期刊文献+

阿托伐他汀强化治疗对冠状动脉血流缓慢综合征患者的影响 被引量:7

Effect of intensive atorvastatin therapy on coronary slow flow syndrome
暂未订购
导出
摘要 目的观察阿托伐他汀强化治疗对冠状动脉血流缓慢(SCF)综合征患者的影响。方法选择28例经冠状动脉造影确诊为SCF综合征的患者为SCF组,口服阿托伐他汀40 mg/d,25例冠状动脉血流正常(NCF)患者作为NCF组。治疗前后,分别检测2组TC、LDL-C、HDL-C、高敏C反应蛋白(hs-CRP)、细胞间黏附分子1(ICAM-1)、血管细胞黏附分子1(VCAM-1)、E选择素;采用超声检测肱动脉血流介导的内皮依赖性血管舒张功能(FMD)和硝酸甘油治疗的非内皮依赖性血管舒张功能(NMD),以冠状动脉血流计帧值法(Timi-FC)评价造影时冠状动脉血流速度。结果与治疗前比较,治疗4周后SCF组Timi-FC、TC、LDL-C、hs-CRP、ICAM-1、VCAM-1及E选择素显著降低(P<0.05),FMD及NMD显著升高(P<0.01);与NCF组比较,hs-CRP、ICAM-1、VCAM-1、E选择素、FMD及NMD无显著差异;与治疗前比较,NCF组随访4周后TC、LDL-C显著降低(P<0.05);Timi-FC与hs-CPC、ICAM-1、VCAM-1和E选择素呈正相关(P<0.01),与FMD、NMD呈负相关(P<0.01)。结论 SCF与血管内皮功能及炎性反应密切相关,他汀类药物强化治疗可降低炎性反应,改善血管内皮功能,提高冠状动脉血流速度。 Objective To observe the effect of intensive atorvastatin therapy on slow coronary flow(SCF) syndrome.Methods Twenty-eight patients with SCF syndrome served as SCF group and 25 subjects with normal coronary flow(NCF) served as NCF group.Patients in SCF group were treated with oral atorvastatin(40 mg/d) for 4 weeks.Serum levels of TC,LDL-C,HDL-C,hs-CRP,ICAM-1,VCAM-1,E-selectin were measured,blood flow-mediated FMD and nitroglycerol-mediated NMD were detected by ultrasonography 4 weeks before and after treatment.Coronary flow rate was measured with Timi-FC.Results The levels of Timi-FC,TC,LDL-C,hs-CRP,ICAM-1,VCAM-1 and Eselectin were significantly lower while the FMD and NMD were significantly higher in SCF group than in NCF group 4 weeks after treatment than before treatment(P〈0.05).No significant difference was found in hs-CRP,ICAM-1,VCAM-1,E-selectin,FMD and NMD between the two groups.The levels of TC and LDL-C were significantly lower in NCF group 4 weeks after treatment than before treatment(P〈0.05).The TimiFC was positively related with hs-CRP,ICAM-1,VCAM-1 and E-selectin and negatively related with FMD and NMD(P〈0.01).Conclusion SCF syndrome is closely related with decreased vascular endothelial function and inflammatory response.Intensive atorvastatin therapy can decrease serum level of inflam-matory factors,improve vascular endothelial function and coronary flow rate in patients with SCF syndrome.
出处 《中华老年心脑血管病杂志》 CAS 北大核心 2012年第5期460-463,共4页 Chinese Journal of Geriatric Heart,Brain and Vessel Diseases
基金 广东省“211工程”三期重点学科建设项目“器官衰竭防治研究”专项资金资助(2011-948)
关键词 冠状动脉疾病 血流速度 冠状血管造影术 胆固醇 LDL 胆固醇 HDL C反应蛋白质 血管细胞黏附分子1 coronary artery disease blood flow velocity coronary angiography cholesterol,LDL cholesterol,HDL Creactive protein vascular cell adhesion molecule1
  • 相关文献

参考文献14

  • 1Sezgin AT, Sigirci A, Barutcu function in patients with slow Dis, 2003,14 : 155-161. I, et al. Vascular endothelial coronary flow. Coron Artery.
  • 2Corretti MC,Anderson TJ,Benjamin EJ, etal. Guidelines for the ultrasound assessment of endothelial dependent flow-me diated vasodilation of the brachial artery: A report of the In- ternational Brachial Artery Reactivity Task Force. J Am Coil Cardiol, 2002,39 : 257-265.
  • 3Turban H, Saydam GS, Erbay AR, et al. Increased plasma sol- uble adhesion molecules ICAM 1, VCAM-1, and E-selectin levels in patients with slow coronary flow. Int J Cardiol, 2006,108 : 224-230.
  • 4Park KW, Kwon YW, Cho HJ, et al. G-CSF exerts dual effects on endothelial cells-opposing actions of direct eNOS in- duction versus indirect CRP elevation. J Mol Cell Cardiol, 2008,45 .- 670-678.
  • 5Xia S, Deng SB, Wang Y, et al. Clinical analysis of the risk factors of slow coronary flow. Heart Vessels, 2011,26:480 486.
  • 6Kim BS, Kim H J, Han SW, et al. Slow coronary flow is related to increased carotid intima media thickness but not pulse wave velocity. Korean Cire J, 2011,41 : 666 670.
  • 7Fan Y, Yang SS, Yu JB, et aI. Atorvastatin use and coronary flow reserve in patients with coronary slow flow. Zhonghua Xin Xue Guan Bing Za Zhi, 2010,38 : 143-146.
  • 8Korkmaz S, Yilmaz MB, Sencan M. How to manage coronary slow flow following PCI? Int J Cardiof,2011,154 : 222 223.
  • 9Patti G, Chello M, Pasceri V, et al. Protection from procedural myocardial injury by atorvastatin is associated with lower lev- els of adhesion molecules after pereutaneous coronary inter vention results from the ARMYDA CAMS substudy. J Am Coll Cardiol, 2006,48 : 1560-1566.
  • 10Nissen SE, Tuzcu EM, Schoenhagen P, et al. Effect of inten sire compared moderate lipid lowering therapy on progression of coronary atherosclerosis: A randomized controlled trial. JAMA, 2004,291 : 1071-1080.

同被引文献60

  • 1陈柏荣,危小良,彭湖,罗礼云,林岫芳.髓过氧化物酶与冠状动脉慢血流的相关性[J].中国动脉硬化杂志,2015,23(2):185-187. 被引量:10
  • 2周滔,杨德光,陈小芳,肖孟,潜学勤.红细胞膜胆固醇水平与非ST抬高型急性冠状动脉综合征患者PCI相关冠状动脉慢血流或无复流发生相关[J].中国动脉硬化杂志,2015,23(4):379-383. 被引量:11
  • 3高润霖.遵循指南规范慢性稳定性心绞痛的诊断和治疗[J].中华心血管病杂志,2007,35(3):193-194. 被引量:75
  • 4Tambe AA, Demany MA, Zimmerman HA, et al. Angina pectoris and slow flow velocity of dye in coronary arteries--a new angiographic finding. Am Heart J, 1972, 84: 66-71.
  • 5Hawkins BM, Stavrakis S, Rousan TA, et al. Coronary slow flow-- prevalence and clinical correlations. Circ J, 2012, 76: 936-942.
  • 6Ekmekci A, G ti ngOr B, Ozcan KS, et al. Evaluation of coronary microvascular function and nitric oxide synthase intron 4a/b polymorphism in patients with coronary slow flow. Coron Artery Dis, 2013, 24: 461-467.
  • 7Mangieri E, Macchiarelli G, Ciavolella M, et al. Slow coronary flow: clinical and histopathological features in patients with otherwise normal epicardial coronary arteries. Cathet Cardiovasc Diagn, 1996, 37: 375-381.
  • 8Erdogan D, Caliskan M, Gullu H, et al. Coronary flow reserve is impaired in patients with slow coronary flow. Atherosclerosis, 2007, 191: 168-174.
  • 9Signori LU, Quadros AS, Sbruzzi G, et al. Endothelial function in patients with slow coronary flow and normal coronary angiography. Clinics, 2012, 67: 677-680.
  • 10Celebi H, Catakoglu AB, Kurtoglu H, et al. The relation between coronary flow rate, plasma endothelin-1 concentrations, and clinical characteristics in patients with normal coronary arteries. Cardiovasc Revasc Med, 2008, 9: 144-148.

引证文献7

二级引证文献65

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部